Tucker Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-101
Closed -$6.79K – 1734
2023
Q4
$6.79K Hold
101
– – ﹤0.01% 807
2023
Q3
$7.56K Hold
101
– – ﹤0.01% 734
2023
Q2
$9.31K Hold
101
– – ﹤0.01% 547
2023
Q1
$10.5K Hold
101
– – ﹤0.01% 536
2022
Q4
$11.5K Hold
101
– – ﹤0.01% 319
2022
Q3
$11.8K Hold
101
– – ﹤0.01% 302
2022
Q2
$18.2K Hold
101
– – 0.01% 179
2022
Q1
$17.2K Buy
+101
New +$19K 0.01% 168

Other funds holding MED

Tucker Asset Management's MED Position: Q1 2024 in Review

Tucker Asset Management sold out of Medifast (MED) in Q1 2024, closing a stake of 101 shares — an estimated $6.79K sold.

Tucker Asset Management first reported a position in MED in Q1 2022 and held it in 8 quarters. The position peaked at $18.2K in Q2 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Tucker Asset Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Tucker Asset Management sold 101 Medifast shares in Q1 2024, an estimated $6.79K.
  • Tucker Asset Management first reported a position in Medifast in Q1 2022 and held it in 8 quarters.
  • Tucker Asset Management's Medifast position peaked at $18.2K in Q2 2022.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Tucker Asset Management's 13F filing for Q1 2024, filed 9 Aug 2024.